02/19/2026
Programming the body to build its own medicine? It’s happening right here in Hamilton.
Meet Esphera SynBio, a Hamilton-based innovator reprogramming the body’s own communication system to manufacture and deliver therapeutics from within.
By leveraging the SOPHIE program and a strategic partnership with McMaster University, Esphera is generating the critical pre-clinical data needed to unlock their $38M Series A and move toward human trials.
Read more about how they are bypassing traditional manufacturing hurdles to transform cancer and infectious disease treatment. 👉 https://loom.ly/gifWbno
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.